Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Tempest Therapeutics Inc have a median target of 13.00, with a high estimate of 47.00 and a low estimate of 5.00. The median estimate represents a 1,354.79% increase from the last price of 0.8936.
High | 5,159.6% | 47.00 |
Med | 1,354.8% | 13.00 |
Low | 459.5% | 5.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | +2.95% |
Average growth rate | +52.91% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼